Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Sep;27(9):2062–2066. doi: 10.1128/jcm.27.9.2062-2066.1989

Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.

D G Schiavini 1, J M Puel 1, S A Averous 1, J A Bazex 1
PMCID: PMC267739  PMID: 2506222

Abstract

Identifying criteria for the early prediction of progression to acquired immunodeficiency syndrome in asymptomatic human immunodeficiency virus-seropositive patients have become necessary in order to widen the indications for antiviral treatment by azidothymidine and to increase its efficiency. With this aim in mind, we studied a cohort of seropositive homosexual men in the southwest region of France (Midi-Pyrénées). Of all the factors analyzed, the decline in p24 antibodies, assayed by second-generation enzyme-linked immunosorbent assay, was found to be the most reliable. On the basis of the work of Blomberg and Schmidt, we developed a quantitative approach to Western blotting (immunoblotting) for use in the follow-up of human immunodeficiency virus-infected patients. Our technique of quantitative Western blotting is unique because it uses a densitometric reading which, through a computerized system, gives a curve allowing the exact quantification of each stained Western blotting band. The results are expressed as integrals. This technique confirms the decrease in p24 and p17 antibodies as the criterion giving the earliest prediction of the progression to acquired immunodeficiency syndrome.

Full text

PDF
2062

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain J. P., Laurian Y., Paul D. A., Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet. 1986 Nov 29;2(8518):1233–1236. doi: 10.1016/s0140-6736(86)92673-5. [DOI] [PubMed] [Google Scholar]
  2. Blomberg J., Klasse P. J. Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis. J Clin Microbiol. 1988 Jan;26(1):111–115. doi: 10.1128/jcm.26.1.111-115.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blomberg J., Klasse P. J. Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting. J Clin Microbiol. 1988 Jan;26(1):106–110. doi: 10.1128/jcm.26.1.106-110.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buimovici-Klein E., Lange M., Klein R. J., Cooper L. Z., Grieco M. H. Is presence of interferon predictive for AIDS? Lancet. 1983 Aug 6;2(8345):344–344. doi: 10.1016/s0140-6736(83)90322-7. [DOI] [PubMed] [Google Scholar]
  5. Carne C. A., Weller I. V., Loveday C., Adler M. W. From persistent generalised lymphadenopathy to AIDS: who will progress? Br Med J (Clin Res Ed) 1987 Apr 4;294(6576):868–869. doi: 10.1136/bmj.294.6576.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davtyan D. G., Vinters H. V. Wernicke's encephalopathy in AIDS patient treated with zidovudine. Lancet. 1987 Apr 18;1(8538):919–920. doi: 10.1016/s0140-6736(87)92892-3. [DOI] [PubMed] [Google Scholar]
  7. DeVita V. T., Jr, Broder S., Fauci A. S., Kovacs J. A., Chabner B. A. Developmental therapeutics and the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Apr;106(4):568–581. doi: 10.7326/0003-4819-106-4-568. [DOI] [PubMed] [Google Scholar]
  8. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  9. Gill P. S., Rarick M., Brynes R. K., Causey D., Loureiro C., Levine A. M. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1987 Oct;107(4):502–505. doi: 10.7326/0003-4819-107-4-502. [DOI] [PubMed] [Google Scholar]
  10. Goedert J. J., Biggar R. J., Weiss S. H., Eyster M. E., Melbye M., Wilson S., Ginzburg H. M., Grossman R. J., DiGioia R. A., Sanchez W. C. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science. 1986 Feb 28;231(4741):992–995. doi: 10.1126/science.3003917. [DOI] [PubMed] [Google Scholar]
  11. Hagler D. N., Frame P. T. Azidothymidine neurotoxicity. Lancet. 1986 Dec 13;2(8520):1392–1393. doi: 10.1016/s0140-6736(86)92029-5. [DOI] [PubMed] [Google Scholar]
  12. Hofbauer J. M., Schulz T. F., Hengster P., Larcher C., Zangerle R., Kofler H., Fritsch P., Wachter H., Dierich M. P. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections. J Clin Microbiol. 1988 Jan;26(1):116–120. doi: 10.1128/jcm.26.1.116-120.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jouvin M. H., Rozenbaum W., Russo R., Kazatchkine M. D. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. AIDS. 1987 Jul;1(2):89–94. [PubMed] [Google Scholar]
  14. Kaplan J. E., Spira T. J., Fishbein D. B., Pinsky P. F., Schonberger L. B. Lymphadenopathy syndrome in homosexual men. Evidence for continuing risk of developing the acquired immunodeficiency syndrome. JAMA. 1987 Jan 16;257(3):335–337. doi: 10.1001/jama.257.3.335. [DOI] [PubMed] [Google Scholar]
  15. Lambin P., Desjobert H., Debbia M., Fine J. M., Muller J. Y. Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet. 1986 Nov 22;2(8517):1216–1216. doi: 10.1016/s0140-6736(86)92219-1. [DOI] [PubMed] [Google Scholar]
  16. Lange J. M., Goudsmit J., De Wolf F., Coutinho R. A., van der Noordaa J. Serological markers in HIV infection. Ann Med Interne (Paris) 1988;139(2):80–83. [PubMed] [Google Scholar]
  17. Lange J. M., de Wolf F., Krone W. J., Danner S. A., Coutinho R. A., Goudsmit J. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. AIDS. 1987 Sep;1(3):155–159. [PubMed] [Google Scholar]
  18. Melbye M., Grossman R. J., Goedert J. J., Eyster M. E., Biggar R. J. Risk of AIDS after herpes zoster. Lancet. 1987 Mar 28;1(8535):728–731. doi: 10.1016/s0140-6736(87)90365-5. [DOI] [PubMed] [Google Scholar]
  19. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Motz M., Soutschek-Bauer E., Frösner G. G., Gürtler L., Schall M., Wolf H. Immunoblot test with recombinant HIV antigens. Lancet. 1987 Nov 7;2(8567):1093–1093. doi: 10.1016/s0140-6736(87)91525-x. [DOI] [PubMed] [Google Scholar]
  21. Murray H. W., Hillman J. K., Rubin B. Y., Kelly C. D., Jacobs J. L., Tyler L. W., Donelly D. M., Carriero S. M., Godbold J. H., Roberts R. B. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med. 1985 Dec 12;313(24):1504–1510. doi: 10.1056/NEJM198512123132403. [DOI] [PubMed] [Google Scholar]
  22. Polk B. F., Fox R., Brookmeyer R., Kanchanaraksa S., Kaslow R., Visscher B., Rinaldo C., Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987 Jan 8;316(2):61–66. doi: 10.1056/NEJM198701083160201. [DOI] [PubMed] [Google Scholar]
  23. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  24. Schechter M. T., Boyko W. J., Craib K. J., McLeod A., Willoughby B., Douglas B., Constance P., O'Shaughnessey M. Effects of long-term seropositivity to human immunodeficiency virus in a cohort of homosexual men. AIDS. 1987 Jul;1(2):77–82. [PubMed] [Google Scholar]
  25. Schmidt G., Amiraian K., Frey H., Stevens R. W., Berns D. S. Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status. J Clin Microbiol. 1987 Oct;25(10):1993–1998. doi: 10.1128/jcm.25.10.1993-1998.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schulz T. F., Aschauer J. M., Hengster P., Larcher C., Wachter H., Fleckenstein B., Dierich M. P. Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection. Lancet. 1986 Jul 12;2(8498):111–112. doi: 10.1016/s0140-6736(86)91648-x. [DOI] [PubMed] [Google Scholar]
  27. Scorza Smeraldi R., Fabio G., Lazzarin A., Eisera N. B., Moroni M., Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet. 1986 Nov 22;2(8517):1187–1189. doi: 10.1016/s0140-6736(86)92197-5. [DOI] [PubMed] [Google Scholar]
  28. Seligmann M., Pinching A. J., Rosen F. S., Fahey J. L., Khaitov R. M., Klatzmann D., Koenig S., Luo N., Ngu J., Riethmüller G. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med. 1987 Aug;107(2):234–242. doi: 10.7326/0003-4819-107-2-234. [DOI] [PubMed] [Google Scholar]
  29. Weber J. N., Clapham P. R., Weiss R. A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R. S., Pinching A. J. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. doi: 10.1016/s0140-6736(87)91964-7. [DOI] [PubMed] [Google Scholar]
  30. de Wolf F., Lange J. M., Goudsmit J., Cload P., de Gans J., Schellekens P. T., Coutinho R. A., Fiddian A. P., van der Noordaa J. Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet. 1988 Feb 20;1(8582):373–376. doi: 10.1016/s0140-6736(88)91179-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES